Yu Young Vancomycin Hydrochloride Injection 1 gram

Adult dosage

For oral administration, 500mg (potency) per day should be divided and given for 7-10 days. In severe cases, 2g (potency) can be administered divided into 3-4 doses per day, and the total daily dosage should not exceed 2g. For injection, 500mg (potency) should be administered every 6 hours or 1g (potency) every 12 hours via intravenous drip. For enterocolitis and pseudomembranous colitis caused by Clostridium difficile.

Children's dosage

For oral administration, 40mg (potency) per kg of body weight should be administered in 3-4 divided doses per day for 7-10 days, and the total daily dosage should not exceed 2g. For injection, 10mg per kg of body weight should be administered as a single dose.

This medication should not be used in patients who have had allergic reactions to this drug or its components. Patients allergic to peptide-based or aminoglycoside antibiotics should use this medication cautiously, and patients with hearing problems or impaired kidney function should also take care. Particularly, patients with impaired kidney function, elderly patients, and those with damage to the vestibular or cochlear structures should be cautious when administering this medication. This medication can rarely cause various side effects, such as shock, decrease in blood cell counts, hearing loss, renal dysfunction, skin rashes, etc., so if any unusual symptoms occur during administration, it should be discontinued immediately, and consultation with medical personnel should occur. To prevent the occurrence of resistant bacteria, it should only be used for a minimal duration after confirming the sensitivity of the infecting organism, and there is a risk of overgrowth of non-sensitive bacteria with prolonged use. This medication carries a risk of auditory toxicity, so regular hearing tests during administration are recommended, and patients with impaired kidney function should frequently undergo renal function tests to adjust the dosage. When used in conjunction with other neurotoxic or nephrotoxic drugs, side effects may exacerbate, so caution is required. Pregnant or breastfeeding women should use this drug cautiously, as the effects on the fetus or infant are not fully understood, and it is advisable to avoid or discontinue use during breastfeeding unless necessary. Children, especially premature infants or newborns, have immature kidney function, which may lead to increased blood levels of this medication, and its administration should be approached with care. In cases of overdose, severe side effects such as renal dysfunction or hearing loss may occur, and immediate appropriate treatment is required, as this medication is not easily removed by dialysis, and special treatment may be necessary. When administering intravenously, it should be infused slowly to prevent hypotension or inflammation at the injection site, and drug turbidity or discoloration should be checked before administration.

Serious side effects

Urticaria, severe swelling (edema), tightness in the chest, difficulty breathing, cold sweat, pallor, severe allergic reactions, severe skin reactions, shortness of breath or difficulty in breathing, asthma attacks, respiratory problems accompanied by cough and fever, yellowing of the skin or eyes (jaundice), extreme lethargy, liver abnormalities (jaundice), sudden severe headache, lightning-like headache, seizures, confusion, visual disturbances, paralysis, serious kidney issues.

Mild side effects

• Oral dysgeusia
• dizziness
• stool changes
• tinnitus
• sweating
• decreased platelet count
• agranulocytosis
• chills
• cold sensation
• drug-induced fever

This medication should be stored in a tightly sealed container to prevent air and moisture from entering. It is best to maintain storage temperatures between 1 and 30 degrees Celsius to ensure the medication's efficacy is preserved safely over time.

Appearance

A white to light yellowish-brown freeze-dried powder in a colorless and transparent vial for injection.

Package unit

1g/vial x 10